China’s stem-cell rules go unheeded

Published in the journal Nature is a report on the unapproved stem-cell treatments and clinics in China. The author David Cyranoski writes that the stem cell trade in China is still quite prevalent despite stronger regulation by the Chinese health ministry.


Health ministry’s attempt at regulation has had little effect.

 

0 comments:

Post a Comment